Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 305.4036
- Book/Share 61.2567
- PB 1.016
- Debt/Equity 1.0691
- CurrentRatio 0.8034
- ROIC 0.0353
- MktCap 78557742000.0
- FreeCF/Share 3.7757
- PFCF 16.4347
- PE 17.3513
- Debt/Assets 0.3202
- DivYield 0.0428
- ROE 0.0595
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
| Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
| Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
| Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
| Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
| Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
CVS Health tops Q2 estimates, lifts full-year guidance
Published: July 31, 2025 by: Proactive Investors
Sentiment: Positive
CVS Health Corp (NYSE:CVS) reported better-than-expected financial results for the second quarter, driven by robust growth across its retail pharmacy, insurance (Aetna), and health services segments. Total revenue was up 8.4% at $98.9 billion, above Wall Street estimates of $94.7 billion.
Read More
PCE Comes in Warmer Than Expected
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Neutral
PCE Comes in Warmer Than Expected.
Read More
Economy Heating Up on PCE for June
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Neutral
Pre-market and bond yield numbers appear to be in reaction to this morning's economic posts.
Read More
CVS Stock Up on Q2 Earnings & Revenue Beat, '25 EPS View Raised
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health beats on Q2 earnings and raises 2025 EPS outlook, lifting shares nearly 8% on strong segment growth and margin gains.
Read More
CVS Health (CVS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
CVS Health Stock Surges After Earnings Smash Forecasts. A Value Play Has Become a Rally.
Published: July 31, 2025 by: Barrons
Sentiment: Positive
The company boosts its full-year guidance range for adjusted earnings on the heels of a strong second quarter.
Read More
63 July Fortune 500 Industry Leaders: 3 Ideal "Safer" Dividend Buys
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Positive
Three Fortune 500 Industry Leaders—Energy Transfer, Verizon, and World Kinect—currently meet the ideal 'dogcatcher' standard for fair-priced, safer dividend stocks. Analyst projections suggest the top ten F500IL 'dogs' could yield 15.1% to 34.8% net gains by July 2026, with lower-than-market volatility. Most high-yield F500IL stocks remain overpriced, but a market correction or dividend increases could bring more into ideal buy territory.
Read More
Is CVS Health (CVS) Stock Outpacing Its Medical Peers This Year?
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how CVS Health (CVS) and Agenus (AGEN) have performed compared to their sector so far this year.
Read More
CVS Health Care Delivery: Will the Growth Momentum Last in Q2?
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS' Health Care Delivery unit posts strong growth from Signify and Oak Street, but rising medical costs pose a near-term risk.
Read More
Buy CVS Stock Ahead of Its Upcoming Earnings?
Published: July 30, 2025 by: Forbes
Sentiment: Neutral
CVS Health (NYSE:CVS) is scheduled to announce its earnings on Thursday, July 31, 2025. For event-driven traders, analyzing the stock's historical behavior around earnings releases can provide valuable context.
Read More
Here's Why CVS Health (CVS) is a Strong Value Stock
Published: July 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Visa, CVS, and 4 More Oversold Stocks Worth a Look Before Earnings
Published: July 25, 2025 by: Barrons
Sentiment: Positive
Stocks that have gained too much are more susceptible to big drops than companies that dropped heading into their results.
Read More
CVS or DHR: Which Is the Better Value Stock Right Now?
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical Services stocks are likely familiar with CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Read More
CVS Health (CVS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Read More
Here's Why CVS Health (CVS) is Poised for a Turnaround After Losing 7.7% in 4 Weeks
Published: July 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
CVS Health (CVS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Read More
5 Low Price-to-Book Stocks That Should Be in Your Portfolio Now
Published: July 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Low P/B stocks like CVS, SIG, KB, AMG and PAGS are flashing value signals with strong EPS growth projections and solid fundamentals.
Read More
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
Published: July 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?
Published: July 18, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
Read More
Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net Income
Published: July 17, 2025 by: Seeking Alpha
Sentiment: Negative
A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecasts. Of the eight largest publicly traded US managed care insurers, all but two — UnitedHealth Group and Alignment Healthcare — are projected to report lower revenue compared with Q1 2025, while all eight are forecast to log higher revenue than Q2 2024. In Q2, all eight of the largest publicly traded US managed care insurers, except The Cigna Group, are expected to log lower net income sequentially, …
Read More
CVS Health - Q2 Earnings Are A Referendum On Future Of Company
Published: July 16, 2025 by: Seeking Alpha
Sentiment: Positive
CVS has transformed from a retail pharmacy to a complex healthcare conglomerate, but its stock price has remained stagnant over the past decade. The Medicare Advantage business, once seen as a growth engine, has become less profitable, leading to management shakeups and activist investor intervention. Despite a short-term recovery in 2025, CVS faces ongoing challenges: declining retail, regulatory threats to PBM, and uncertain Medicare Advantage profitability.
Read More
4 Value Stocks to Buy as Inflation and Market Volatility Rise
Published: July 16, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health, Hudbay Minerals, Universal Health Services and ASB stand out as value stocks amid rising inflation.
Read More
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Published: July 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Here's Why CVS Health (CVS) is a Strong Value Stock
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal?
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: July 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Read More
CVS Health declares quarterly dividend
Published: July 07, 2025 by: PRNewsWire
Sentiment: Neutral
WOONSOCKET, R.I. , July 7, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.
Read More
Can CVS Sustain Pharmacy & Consumer Wellness Gains Through Year-End?
Published: July 04, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health's CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was supported by seasonal trends, including the impact of high vaccine demand and a longer-than-usual flu season.
Read More
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Negative
CVS Health (CVS) closed at $66.6 in the latest trading session, marking a -4.28% move from the prior day.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO J. David Joyner CEBS
- Employees 219000